Atopic Dermatitis Clinical Trials in Tampa, Florida

4 studies are recruiting for atopic dermatitis in Tampa, Florida right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic Dermatitis

    This is a phase 2b, multicenter, randomized, double-blind, placebo-controlled study.

    Stage
    Phase 2
    Ages
    18 to 65
    Site
    NMC Research LLC, Tampa, Florida
    Locations
    85 in total
    Run by
    Apollo Therapeutics Ltd

    See if you can join NCT07599813 on ClinicalTrials.gov

  2. A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

    The purpose of this study is to evaluate the efficacy and safety of different dose regimens of IMG-007, compared to placebo.

    Stage
    Phase 2
    Ages
    18 to 74
    Site
    Inmagene Site 4, Tampa, Florida
    Locations
    30 in total
    Run by
    Inmagene LLC

    See if you can join NCT07037901 on ClinicalTrials.gov

  3. A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis

    The purpose of this trial is to test whether treatment with tralokinumab (administered subcutaneous injections [SC]) in combination with topical corticosteroids (TCS) is safe and effective to treat moderate-to-severe atopic dermatitis (AD) in children and infants. This will be judged by a range of …

    Stage
    Phase 3
    Ages
    0 to 11
    Site
    Leo Pharma Investigational site, Tampa, Florida
    Locations
    72 in total
    Run by
    LEO Pharma

    See if you can join NCT06311682 on ClinicalTrials.gov

  4. Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults

    The main aim of the study is to assess real-world effectiveness of nemolizumab in Atopic Dermatitis (AD) as measured by physician assessment and patient reported outcome (PRO) in clinical practice at Month 6.

    Stage
    Not phased
    Ages
    12 and older
    Site
    Galderma Investigational Site 7054, Tampa, Florida
    Locations
    108 in total
    Run by
    Galderma R&D

    See if you can join NCT06988605 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.